Strategic report Governance & remuneration Financial statements Investor information 9 Employee costs 2015 2014 2013 m m m Wages and salaries 6,132 5,879 6,262 Social security costs 633 639 685 Pension and other post-employment costs, including augmentations Note 28 467 403 170 Cost of share-based incentive plans 349 346 319 Severance and other costs from integration and restructuring activities 449 253 155 8,030 7,520 7,591 The Group provides benets to employees, commensurate with local practice in individual countries, including, in some markets, healthcare insurance, subsidised car schemes and personal life assurance.
The charge for pension and other post-employment costs in 2013 includes a credit of 279 million following a restructuring of US post-retirement medical obligations.
These are set out in Note 28, Pensions and other post-employment benets.
The cost of share-based incentive plans is analysed as follows: 2015 2014 2013 m m m Share Value Plan 307 302 243 Performance Share Plan 26 20 47 Share option plans 4 34 Other plans 12 21 25 349 346 319 The average number of persons employed by the Group including Directors during the year was: 2015 2014 2013 Number Number Number Manufacturing 37,025 31,726 31,586 Selling, general and administration 52,121 54,618 55,660 Research and development 12,046 12,358 12,571 101,192 98,702 99,817 The average number of Group employees excludes temporary and contract staff.
The numbers of Group employees at the end of each financial year are given in the financial record on page 224.
The average number of persons employed by GlaxoSmithKline plc in 2015 was nil 2014 nil.
The compensation of the Directors and Senior Management members of the CET in aggregate, was as follows: 2015 2014 2013 m m m Wages and salaries 23 19 23 Social security costs 2 33 Pension and other post-employment costs 3 33 Cost of share-based incentive plans 18 13 13 46 38 42 GSK Annual Report 2015 155
